Who should have breast magnetic resonance imaging evaluation?

Journal of Clinical Oncology

Volumn 26, Issue 5, 2008, Pages 703-711

  Orel, Susan ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST DISCHARGE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CLINICAL PRACTICE; HIGH RISK POPULATION; HUMAN; IMAGING; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; TUMOR BIOPSY; AXILLA; BREAST DISEASE; BREAST TUMOR; CANCER OF UNKNOWN PRIMARY SITE; ECHOMAMMOGRAPHY; FEMALE; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; MASS SCREENING; NIPPLE; SECRETIONS;

AXILLA; BODILY SECRETIONS; BREAST DISEASES; BREAST NEOPLASMS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; NIPPLES; PHYSICAL EXAMINATION; ULTRASONOGRAPHY, MAMMARY;

EID: 39149144544     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.3594     Document Type: Review

References (55)

1. Orel SG: High resolution MR imaging for the detection, diagnosis and staging of breast cancer. RadioGraphics 18:903-912, 1998
2. Dao TH, Rahmouni A, Campana F, et al: Tumor recurrence versus fibrosis in the irradiated breast: Differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 187:751-755, 1993
3. Lee CH, Smith RC, Levine JA, et al: Clinical usefulness of MR imaging of the breast in the evaluation of the problematic mammogram. AJR Am J Roentgenol 173:1323-1329, 1999
4. Kelcz F, Santyr G: Gadolinium-enhanced breast MRI. Crit Rev Diagn Imaging 36:287-338, 1995
5. Stomper PC, Herman S, Klippenstein DL, et al: Suspect breast lesions: Findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 197:387-395, 1995
6. Orel SG, Mendonca MH, Reynolds C, et al: MR imaging of ductal carcinoma in situ. Radiology 202:413-420, 1997
7. Gilles R, Zafrani B, Guinebretiere JM, et al: Ductal carcinoma in situ: MR imaging - Histopathologic correlation. Radiology 196:415-419, 1995
8. Ghai S, Muradali D, Bukhanor K, et al: Nonenhancing breast malignancies on MRI: Sonographic and pathologic correlation. AJR 185:481-487, 2005
9. Boetes C, Strijk SP, Holland R, et al: False-negative MR imaging of malignant breast tumors. Eur Radiol 7:1231-1234, 1997
10. Teifke A, Hlawatsch A, Beier T, et al: Undetected malignancies of the breast: Dynamic contrast-enhanced MR imaging at 1.0T. Radiology 224:881-888, 2002
11. Solin LJ: Special considerations, in Fowble B, Goodman RL, Glick JH, et al (eds): Breast Cancer Treatment: A Comprehensive Guide to Management. St Louis, MO, Mosby Yearbook, 1991, pp 523-528
12. Morris EA, Schwartz LH, Dershaw DD, et al: MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 205:437-440, 1997
13. Orel SG, Weinstein SP, Schnall MD, et al: Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 212:543-549, 1999
14. Van Goethem M, Tjalma W, Schelfout I, et al: Magnetic resonance imaging in breast cancer. EJSO 32:901-910, 2006
15. Chen C, Orel SG, Harris E, et al: Outcome after treatment of patients with mammographically occult, magnetic resonance imaging-detected breast cancer presenting with axillary lymphadenopathy. Clin Breast Cancer 5:72-77, 2004
16. Helvie MA, Joynt LK, Cody RL, et al: Locally advanced breast carcinoma: Accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology 198:327-332, 1996
17. Partridge SC, Gibbs JE, Lu Y, et al: Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR 179:1193-1199, 2002
18. Rieber A, Brambs HJ, Gabelmann A, et al: Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 12:1711-1719, 2002
19. Cheung YC, Chen SC, Su MY, et al: Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Res Treat 78:51-58, 2003
20. Belli P, Romani M, Costantini M, et al: Role of magnetic resonance imaging in the pre and postchemotherapy evaluation in locally advanced breast carcinoma. Rays 27:279-290, 2002
21. Bollet MA, Thibault F, Bouillon K, et al: Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: A prospective phase II study. Int J Radiat Oncol Bio Phys 69:13-18, 2007
22. Segara D, Krop IE, Garber JE, et al: Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? J Surg Oncol 96:474-480, 2007
23. Wasser K, Sinn HP, Fink C, et al: Accuracy of tumor size measurement in breast cancer using MRI is influenced by histologic regression induced by neoadjuvant chemotherapy. Eur Radiol 13:1213-1223, 2003
24. Denis F, Desbiez-Bourcier AV, Chapiron C, et al: Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. Eur J Surg Oncol 30:1069-1076, 2004
25. Kwong MS, Chung GG, Horwath LJ, et al: Postchemotherapy MRI overestimates residual disease compared with histopathology in responders to neoadjuvant therapy for locally advanced breast cancer. Cancer J 12:212-221, 2006
26. Kuhl CK, Schrading S, Leutner CC, et al: Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469-8476, 2005
27. Leach MO, Boggis CR, Dixon AK, et al: Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet 365:1769-1778, 2005
28. Warner E, Plewes DB, Hill KA, et al: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317-1325, 2004
29. Kriege M, Brekelmans CT, Boetes C, et al: Efficacy of MRI and mammography for breastcancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437, 2004
30. Lehman DC, Issacs C, Schnall MD, et al: Cancer yield of mammography, MR, and US in high-risk women: Prospective multi-institution breast cancer screening study. Radiology 244:381-388, 2007
31. Sardanelli F, Podo F, A'Angolo G, et al: Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 242:698-715, 2007
32. Saslow D, Boetes C, Burke W, et al: American cancer society guidelines for breast cancer screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75-89, 2007
33. Port ER, Park A, Borgen PI, et al: Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol 14:1051-1057, 2007
34. Tjalma W, Verslegers I: Nipple discharge and the value of MR imaging. Eur J Obstet Gynecol Reprod Biol 115:234-236, 2004
35. Orel SG, Dougherty CS, Reynolds C, et al: MR imaging in patients with nipple discharge: Initial experience. Radiology 216:248-254, 2000
36. Nakahara H, Namba K, Wantanabe R, et al: A comparison of MR imaging, galactography, and ultrasonography in patients with nipple discharge. Breast Cancer 10:320-329, 2003
37. Yoshimoto M, Kasumi F, Iwase T, et al: Magnetic resonance galactography for a patient with nipple discharge. Breast Cancer Res Treat 42: 87-90, 1997
38. Orel SG, Schnall MD, Powell CM, et al: Staging of suspected breast cancer: Effect of MR imaging and MR-guided biopsy. Radiology 196:115-122, 1995
39. Boetes C, Mus RD, Holland R, et al: Breast tumors: Comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 197:743-747, 1995
40. Essermann L, Hylton N, Yassa L, et al: Utility of magnetic resonance imaging in the management of breast cancer: Evidence for improved preoperative staging. J Clin Oncol 17:110-119, 1999
41. Fischer U, Kopka L, Grabbe E: Breast carcinoma: Effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213:881-888, 1999
42. Weinstein SP, Orel SG, Heller R, et al: MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol 176:399-406, 2001
43. Rodenko GN, Harms SE, Pruneda JM, et al: MR imaging in the management before surgery of lobular carcinoma of the breast: Correlation with pathology. AJR Am J Roentgenol 167:1415-1419, 1996
44. Orel SG, Reynolds C, Schnall MD: Breast carcinoma: MR imaging before reexcisional biopsy. Radiology 205:429-436, 1997
45. Fischer U, Baum F, Luftner-Nagel S: Preoperative MR imaging in patients with breast cancer: Preoperative staging, effects on recurrence rates, and outcome analysis. Magn Reson Imaging Clin N Am 14:351-362, vi, 2006
46. Liberman L: Breast MR imaging in assessing extent of disease. Magn Reson Imaging Clin N Am 14:339-349, vi, 2006
47. Tillman G, Orel SG, Schnall MD, et al: Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast cancer. J Clin Oncol 20:3413-3423, 2002
48. Mann RM, Veltman J, Barentsz JO, et al: The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma. Eur J Surg Oncol 14, 2007
49. Beatty JD, Porter BA: Contrast-enhanced breast magnetic resonance imaging: The surgical perspective. Am J Surg 193:600-605, 2007
50. Bilimoria KY, Cambic A, Hansen NM, Bethke KP: Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch Surg 142:441-445, 2007
51. Bennion RS, Love SM: Treatment of breast disease, in Bassett LW, Jackson VP, Jahan R (eds): Diagnosis of Diseases of the Breast. Philadelphia, PA, Saunders, 1997, pp 521-545
52. Lee SG, Orel SG, Woo IJ, et al: MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: Preliminary results. Radiology 226:773-778, 2003
53. Liberman L, Morris EA, Kim CM, et al: MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180:333-341, 2003
54. Pediconi F, Catalano C, Roselli A, et al: Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer. Radiology 243:670-680, 2007
55. Lehman CD, Gatsonis C, Kuhl CK, et al: MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295-1303, 2007